Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing

NCT03346694 · View on ClinicalTrials.gov ↗

Study Summary

This study will evaluate two alternative dressings compared to a standard Island dressing presently in use at Stanford Hospital to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients. Cardiovascular surgery patients who will have a sternotomy incision as a routine part of their surgery will be approached to voluntarily participate. Participants will be randomized to one of three dressing to determine which dressing has the lowest rate of sternal wound infection. The investigators will also assess the impact of alternative dressing use on hospital 30-day readmission rates related to SSI.

Conditions Studied

Interventions

  • DEVICE Standard Island Dressing
  • DEVICE Prevena Negative Pressure wound dressing
  • DEVICE Mepilex Border Post-Op Ag

Study Locations (1)

California

  • Stanford Healthcare — Stanford

Trial Details

FieldValue
Enrollment Target 660 participants
Start Date 2018-05-01
Est. Completion 2035-05-01
Phase NA

Sponsor

Stanford University

1,643 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03346694

The ClinicalTrials.gov registry entry for NCT03346694 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 660 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,643 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Wound of Skin appearing as the primary indexed condition, and to 3 interventions — of which Standard Island Dressing is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT03346694 reports 1 study location spanning 1 distinct geographic area — top geographies include California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT03346694 about?

NCT03346694 is a clinical study titled "Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing". This study will evaluate two alternative dressings compared to a standard Island dressing presently in use at Stanford Hospital to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients. Cardiovascular surgery patients who will have a sternotomy incision as a rout...

What is the current status of trial NCT03346694?

This trial is currently recruiting. It is a NA study. The enrollment target is 660 participants. The study started on 2018-05-01. Estimated completion is 2035-05-01.

What conditions does trial NCT03346694 study?

This clinical trial studies the following conditions: Wound of Skin. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT03346694?

The interventions under investigation include: Standard Island Dressing (DEVICE), Prevena Negative Pressure wound dressing (DEVICE), Mepilex Border Post-Op Ag (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT03346694?

This trial is sponsored by Stanford University, which has 1,643 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT03346694 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial